Basic Information
| LncRNA/CircRNA Name | GHET1 |
| Synonyms | NA |
| Region | GRCh38_7:148987527-148989432 |
| Ensemble | ENSG00000281189 |
| Refseq | NR_130107 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | Cervical Cancer |
| ICD-0-3 | C53 |
| Methods | qPCR |
| Sample | cervical cancer tissue,cell lines(Ect1/E6E7SiHa, C-33A, Hela and CaSki) |
| Expression Pattern | up-regulated |
| Function Description | In our study, we found GHET1 expression was markedly elevated in cervical cancer tissue specimens and cell lines compared to adjacent normal cervical tissue specimens and human normal cervical cell line |
| Pubmed ID | 30948501 |
| Year | 2019 |
| Title | GHET1 acts as a prognostic indicator and functions as an oncogenic lncRNA in cervical cancer. |
External Links
| Links for GHET1 | GenBank HGNC NONCODE |
| Links for Cervical Cancer | OMIM COSMIC |